These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 34998277)
1. Assessing community pharmacists' attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland. Heinrich CH; Donovan MD Int J Pharm Pract; 2022 Jan; 30(1):28-35. PubMed ID: 34998277 [TBL] [Abstract][Full Text] [Related]
2. Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes. El-Dahiyat F; Jairoun AA; Al-Hemyari SS; Shahwan M; Hassan N; Jairoun S; Jaber AAS Int J Pharm Pract; 2023 Jun; 31(4):387-395. PubMed ID: 37116892 [TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' perceptions on providing fall prevention services: a mixed-methods study. Gemmeke M; Koster ES; Rodijk EA; Taxis K; Bouvy ML Int J Clin Pharm; 2021 Dec; 43(6):1533-1545. PubMed ID: 34121152 [TBL] [Abstract][Full Text] [Related]
4. Care of the stroke patient-communication between the community pharmacist and prescribers in the Republic of Ireland. Grimes T; Duggan C; Gallagher P; Strawbridge J Pharm World Sci; 2009 Dec; 31(6):648-55. PubMed ID: 19757142 [TBL] [Abstract][Full Text] [Related]
5. Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study. Lüthold RV; Cateau D; Jenkinson SP; Streit S; Jungo KT BMC Health Serv Res; 2024 Jul; 24(1):849. PubMed ID: 39061037 [TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences. Cadogan CA; Ryder SA Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294 [TBL] [Abstract][Full Text] [Related]
7. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study. Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551 [TBL] [Abstract][Full Text] [Related]
8. Community pharmacists' attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation. Ceulemans M; Liekens S; Van Calsteren K; Allegaert K; Foulon V Res Social Adm Pharm; 2020 Sep; 16(9):1192-1200. PubMed ID: 31864884 [TBL] [Abstract][Full Text] [Related]
9. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel. Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042 [TBL] [Abstract][Full Text] [Related]
10. Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study. Hashmi F; Hassali MA; Saleem F; Saeed H; Islam M; Malik UR; Atif N; Babar ZU Int J Clin Pharm; 2021 Aug; 43(4):1090-1100. PubMed ID: 33411180 [TBL] [Abstract][Full Text] [Related]
11. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature. Awaisu A; Alsalimy N Res Social Adm Pharm; 2015; 11(6):725-48. PubMed ID: 25698363 [TBL] [Abstract][Full Text] [Related]
12. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study. Kua CH; Mak VS; Lee SWH BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786 [TBL] [Abstract][Full Text] [Related]
13. The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers. Shami R; Alam MF; ElHajj MS Int J Clin Pharm; 2022 Feb; 44(1):214-226. PubMed ID: 34661831 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Aburuz S; Al-Ghazawi M; Snyder A Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931 [TBL] [Abstract][Full Text] [Related]
15. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design. Buss VH; Shield A; Kosari S; Peterson GM; Naunton M Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556 [TBL] [Abstract][Full Text] [Related]
16. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Alzubaidi H; Saidawi W; Mc Namara K Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256 [TBL] [Abstract][Full Text] [Related]
17. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China. Xi X; Huang Y; Lu Q; Ung COL; Hu H Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer health promotion in Qatar: a survey of community pharmacists' interests and needs. El Hajj MS; Hamid Y Int J Clin Pharm; 2013 Jun; 35(3):376-85. PubMed ID: 21153487 [TBL] [Abstract][Full Text] [Related]
19. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists. Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097 [TBL] [Abstract][Full Text] [Related]
20. Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study. Bužančić I; Ortner Hadžiabdić M Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]